What are artemisinin concept stocks?

Artemisinin is the best drug to treat malaria drug resistance, and the combination therapy based on artemisinin is also the most effective and important means to treat malaria at present. However, in recent years, with the deepening of research, other functions of artemisinin have been found and applied more and more, such as anti-tumor, treatment of pulmonary hypertension, anti-diabetes, embryotoxicity, antifungal, immunomodulation, antivirus, anti-inflammatory, anti-pulmonary fibrosis, antibacterial and cardiovascular effects. What are the related artemisinin concept stocks?

List of artemisinin concept stocks

1, 603880 Nanwei shares: The actual controller holds about two organisms to engage in research and development of immunosuppressive drugs, and the main research and development product is artemisinin derivative arteether amine maleate for the treatment of systemic lupus erythematosus.

2. Baiyun Mountain 600332: The company has the approval of artemisinin, and its subsidiary Guangzhou Hanfang has the first green production line for extracting artemisinin, with an annual output of 3 tons of artemisinin.

3.600 196 Fosun Pharma: artesunate, a controlled subsidiary of Guilin South Medicine, was officially certified by WHPQ on 20 10, and three of the five compounds recommended by WHO contained artesunate. Artesyn (artesunate for injection) is the first drug in the world and has become the first choice for the treatment of severe malaria strongly recommended by WHO.

4.6002 16 Zhejiang Medicine: Novartis Keteng (a component of artemether+benflumetol) is a supplier of benflumetol, and there are batches of artemether raw materials.

5.600422 Kunyao Group: Kunyao Group has long-term cooperation with the Tu Youyou team and invested heavily in patents. In 20 18, the production income of antimalarial drugs was nearly 70 million, accounting for about 7 billion 1% of the company's total income. But the gross profit margin of 70 million yuan is higher, exceeding 50%.

6.002923 Rundu shares: The company is developing dihydroartemisinin piperaquine tablets.

7.600062 China Resources Shuanghe: It has the approval of dihydroartemisinin preparation, and its subsidiary produces dihydroartemisinin tablets.

8.002437 Yuheng Pharmaceutical: The company has patents related to artemisinin-pharmaceutical compositions containing artemisinin and artemisinin derivatives, histone deacetylase inhibitors and their applications.

9.600267 Haizheng Pharmaceutical Co., Ltd.: The company develops the efficient synthesis process of artemisinin and studies the industrialization of related drugs.

10,002821Kelley: The company approved artemisinin to produce artemisinin and its derivatives (including dihydroartemisinin, artesunate, artemether, etc.